Die Ergebnisse können Gästen nur in Auswahl angezeigt werden. Bitte loggen Sie sich für Vollzugriff ein: Login

Treffer: Soft Tissue Sarcoma Guidelines

Title:
Soft Tissue Sarcoma Guidelines
Authors:
Jeffrey D. Wayne, Karen D. Schupak, Richard J. O'Donnell, Ernest U. Conrad, David S. Ettinger, G. Douglas Letson, Gina Z. D'Amato, Charlotte D. Jacobs, William G. Kraybill, Thomas F. DeLaney, John D. Pfeifer, Laurence H. Baker, Ray Hutchinson, Ephraim S. Casper, Margaret von Mehren, R. Lor Randall, Robert S. Benjamin, Krystyna Kiel, George D. Demetri, Douglas S. Tyler, Aaron R. Sasson, Raphael E. Pollock, Robert K. Heck, Martin J. Heslin, I. Benjamin Paz
Source:
Journal of the National Comprehensive Cancer Network. 5:364
Publisher Information:
Harborside Press, LLC, 2007.
Publication Year:
2007
Subject Terms:
Oncology, medicine.medical_specialty, Chemotherapy, Retroperitoneal sarcomas, business.industry, General surgery, medicine.medical_treatment, Soft tissue sarcoma, medicine.disease, Radiation therapy, Clinical Practice, Internal medicine, medicine, business
ISSN:
1540-1413
1540-1405
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed08472038b30a2a9f190ddd614a8b62
https://doi.org/10.6004/jnccn.2007.0034
Rights:
OPEN
Accession Number:
edsair.doi...........ed08472038b30a2a9f190ddd614a8b62
Database:
OpenAIRE

Weitere Informationen

Soft tissue sarcomas are the most frequent sarcomas; the annual incidence for 2007 in the United States is estimated at about 9220 cases, with an overall mortality rate of approximately 3560 cases per year. Important updates for the 2007 version of the guidelines include the addition of epirubicin (single agent) and the combination of epirubicin, ifosfamide, and mesna as generally accepted systemic therapy. Imatinib was added as an option for desmoid tumors. For the most recent version of the guidelines, please visit NCCN.org